-The Hindu   The absence of a comprehensive rehabilitation policy for surrendered militants has made life hellish for those who decided to give themselves up and join the mainstream Jammu & Kashmir's first "Surrender Policy" was floated by Governor Gen. (retd.) K.V. Krishna Rao's Administration in 1995. It was almost identical to the policies introduced for militants involved in the North East and Naxalite insurgencies: Rs.1.5 lakh worth of fixed deposit receipts payable...

-The Hindu   "It deserves to be thrown into the dustbin" The Supreme Court on Thursday rejected the magisterial probe report on the Tarn Taran incident, in which a girl and her father were beaten up by the Punjab police, as it justified the attack on the duo. A Bench of Justices G.S. Singhvi and Kurian Joseph told Additional Solicitor-General Siddharth Luthra, appearing for the Punjab government, "the report does not have the value...

-The Indian Express Chennai: The fate of Sterlite Industries, and that of thousands of people of coastal Tuticorin, now depends on the south bench of the National Green Tribunal, which is hearing the company's petition against its closure ordered by the Tamil Nadu Pollution Control Board (TNPCB). The biggest copper smelting unit in the country, part of the Vedanta Group, moved the tribunal after the TNPCB ordered closure of the plant following...

-The Hindu   People's Movement Against Nuclear Energy to lay siege to township tomorrow TIRUNELVELI: The Kudankulam Nuclear Power Project has "successfully completed" the mandatory penultimate tests before commissioning its first unit by testing an array of steam relief valves under operating pressure and temperature. The tests, started on last Friday to evaluate the performance of high-precision steam relief valves at operating pressure and temperature, were completed on Monday. "We're immensely satisfied with the...

-The Times of India The Supreme Court on Monday rejected pharma giant Novartis AG's plea to preserve its patent over a life-saving cancer drug, Glivec, drawing a huge sigh of relief from thousands of patients in India and in dozens of developing countries as the fear of an almost 15-fold escalation of drug costs receded. It is the biggest setback for multinational pharma companies, which have been denied patent protection...